Cargando…

Safety analysis in patients with autoimmune disease receiving allogeneic mesenchymal stem cells infusion: a long-term retrospective study

OBJECTIVE: The aim of this study was to evaluate the safety of mesenchymal stem cell infusion in patients with autoimmune diseases. METHODS: A total of 404 patients with autoimmune diseases who received mesenchymal stem cell infusion between 2007 and 2016 were included in this study. Adverse events...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Jun, Zhang, Huayong, Kong, Wei, Deng, Wei, Wang, Dandan, Feng, Xuebing, Zhao, Cheng, Hua, Bingzhu, Wang, Hong, Sun, Lingyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6236873/ https://www.ncbi.nlm.nih.gov/pubmed/30428931 http://dx.doi.org/10.1186/s13287-018-1053-4

Ejemplares similares

Sustained benefit from combined plasmapheresis and allogeneic mesenchymal stem cells transplantation therapy in systemic sclerosis
por: Zhang, Huayong, et al.
Publicado: (2017)

A Long-Term Follow-Up Study of Allogeneic Mesenchymal Stem/Stromal Cell Transplantation in Patients with Drug-Resistant Systemic Lupus Erythematosus
por: Wang, Dandan, et al.
Publicado: (2018)

Double Allogenic Mesenchymal Stem Cells Transplantations Could Not Enhance Therapeutic Effect Compared with Single Transplantation in Systemic Lupus Erythematosus
por: Wang, Dandan, et al.
Publicado: (2012)

Umbilical Cord-Derived Mesenchymal Stem Cells Inhibit Cadherin-11 Expression by Fibroblast-Like Synoviocytes in Rheumatoid Arthritis
por: Zhao, Cheng, et al.
Publicado: (2015)

Allogenic Umbilical Cord-Derived Mesenchymal Stromal Cells Sustain Long-Term Therapeutic Efficacy Compared With Low-Dose Interleukin-2 in Systemic Lupus Erythematosus
por: Cao, Zhouli, et al.
Publicado: (2023)

Olf1/EBF associated zinc finger protein interfered with antinuclear antibody production in patients with systemic lupus erythematosus
por: Feng, Xuebing, et al.
Publicado: (2010)

Efficacy and safety of mesenchymal stem cells co-infusion in allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis
por: Li, Teng, et al.
Publicado: (2021)

Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty
por: Golpanian, Samuel, et al.
Publicado: (2017)

Association Between Mycophenolate Mofetil Use and Subsequent Infections Among Hospitalized Patients with Systemic Lupus Erythematosus: A Nested Case–Control Study
por: Guo, Qingqing, et al.
Publicado: (2023)

Inhibition of Aberrant Circulating Tfh Cell Proportions by Corticosteroids in Patients with Systemic Lupus Erythematosus
por: Feng, Xuebing, et al.
Publicado: (2012)

Mesenchymal Stem Cells from Patients with Rheumatoid Arthritis Display Impaired Function in Inhibiting Th17 Cells
por: Sun, Yue, et al.
Publicado: (2015)

Transplantation of mesenchymal stem cells in a laryngeal carcinoma patient with radiation myelitis
por: Liang, Jun, et al.
Publicado: (2015)

Allogeneic mesenchymal stem cells inhibited T follicular helper cell generation in rheumatoid arthritis
por: Liu, Rui, et al.
Publicado: (2015)

A CD8 T Cell/Indoleamine 2,3-Dioxygenase Axis Is Required for Mesenchymal Stem Cell Suppression of Human Systemic Lupus Erythematosus
por: Wang, Dandan, et al.
Publicado: (2014)

Prognostic Factors for Clinical Response in Systemic Lupus Erythematosus Patients Treated by Allogeneic Mesenchymal Stem Cells
por: Wen, Lihui, et al.
Publicado: (2019)

Mesenchymal Stem Cells Promote the Osteogenesis in Collagen-Induced Arthritic Mice through the Inhibition of TNF-α
por: Liu, Chang, et al.
Publicado: (2018)

Characterization of dynamical changes in vital signs during allogeneic human umbilical cord-derived mesenchymal stem cells infusion
por: Wang, Yue, et al.
Publicado: (2023)

Comprehensive expression profile of long non-coding RNAs in Peripheral blood mononuclear cells from patients with neuropsychiatric systemic lupus erythematosus
por: Geng, Linyu, et al.
Publicado: (2020)

Serum IFN‐γ Predicts the Therapeutic Effect of Mesenchymal Stem Cells Transplantation in Systemic Lupus Erythematosus Patients
por: Wang, Dandan, et al.
Publicado: (2017)

Safety and efficacy of intravenous infusion of allogeneic cryopreserved mesenchymal stem cells for treatment of chronic kidney disease in cats: results of three sequential pilot studies
por: Quimby, Jessica M, et al.
Publicado: (2013)

Umbilical Cord-Derived Mesenchymal Stem Cells Suppress Autophagy of T Cells in Patients with Systemic Lupus Erythematosus via Transfer of Mitochondria
por: Chen, Jinyun, et al.
Publicado: (2016)

Development of Clinical Decision Models for the Prediction of Systemic Lupus Erythematosus and Sjogren’s Syndrome Overlap
por: Han, Yan, et al.
Publicado: (2023)

Intraperitoneal Infusion of Mesenchymal Stem/Stromal Cells Prevents Experimental Autoimmune Uveitis in Mice
por: Oh, Joo Youn, et al.
Publicado: (2014)

Association of TNF-α with Impaired Migration Capacity of Mesenchymal Stem Cells in Patients with Systemic Lupus Erythematosus
por: Geng, Linyu, et al.
Publicado: (2014)

Safety and Feasibility of Repeated Intrathecal Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells in Patients with Neurological Diseases
por: Pan, Kuang, et al.
Publicado: (2019)

Safety study of allogeneic mesenchymal stem cell therapy in animal model
por: Chan, Alvin Man Lung, et al.
Publicado: (2022)

Reduced Let-7f in Bone Marrow-Derived Mesenchymal Stem Cells Triggers Treg/Th17 Imbalance in Patients With Systemic Lupus Erythematosus
por: Geng, Linyu, et al.
Publicado: (2020)

Immune Regulatory Properties of Allogeneic Adipose-Derived Mesenchymal Stem Cells in the Treatment of Experimental Autoimmune Diabetes
por: Bassi, Ênio J., et al.
Publicado: (2012)

Treatment of allosensitized patients receiving allogeneic transplantation
por: Ciurea, Stefan O., et al.
Publicado: (2021)

Characteristics of Hearing Loss in Patients with Systemic Lupus Erythematosus
por: Chen, Huixian, et al.
Publicado: (2022)

Safety and long-term improvement of mesenchymal stromal cell infusion in critically COVID-19 patients: a randomized clinical trial
por: Rebelatto, Carmen Lúcia Kuniyoshi, et al.
Publicado: (2022)

P1365: DONOR LYMPHOCYTE INFUSION IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: RESULTS FROM A RETROSPECTIVE STUDY
por: Rochate, D., et al.
Publicado: (2022)

Safety and tracking of intrathecal allogeneic mesenchymal stem cell transplantation in healthy and diseased horses
por: Barberini, Danielle Jaqueta, et al.
Publicado: (2018)

Allogeneic Bone Marrow–Derived Mesenchymal Stem Cell Safety in Idiopathic Parkinson's Disease
por: Schiess, Mya, et al.
Publicado: (2021)

Mesenchymal stem cells for treating autoimmune dacryoadenitis
por: Lu, Xiaoxiao, et al.
Publicado: (2017)

Allogeneic CD19-CAR-T cell infusion after allogeneic hematopoietic stem cell transplantation in B cell malignancies
por: Liu, Jun, et al.
Publicado: (2017)

Allogeneic Umbilical Cord Blood Infusion for Adults with Ischemic Stroke: Clinical Outcomes from a Phase I Safety Study
por: Laskowitz, Daniel T., et al.
Publicado: (2018)

Safety and feasibility study of ex vivo expanded allogeneic-NK cells infusion in patients with acute pneumonia caused by COVID-19
por: Ahmadvand, Mohammad, et al.
Publicado: (2023)

Immunogenicity of allogeneic mesenchymal stem cells
por: Schu, Sabine, et al.
Publicado: (2012)

Allogeneic stem cell transplantation for rheumatic autoimmune diseases
por: Hügle, Thomas, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_q0acnjb375ufgoc5i21289bsq5